New Study Highlights the Utility of the FebriDx® Test for Rapid Triage and Identification of COVID-19
Lumos is unique in offering the full range of in-house expertise required to deliver a complete, commercially-ready solution.
Lumos has specific expertise in developing assays across a range of POC, chemistry and technology platforms. These can be configured as stand-alone, manual-read products or interfaced with Lumos readers or third-party hardware for fully automated solutions.
Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. Our reader platforms act as a starting point to reduce overall product development effort and timeline. They are easily customizable to meet partner and/or end user needs and price points.
Cloud & Data
Lumos has developed a digital cloud platform that enables our clients to leverage the cloud to create an entire product ecosystem that enhances reader capability. We work collaboratively with you to customize our platform and develop a specific solution that fits your exact needs.
Reach out to Lumos today to understand how we can deliver you a customized point-of-care diagnostic solution.